The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccrol Gp Regulatory News (ACRL)

Share Price Information for Accrol Gp (ACRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 39.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 39.00
ACRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of second ESG Report

28 Nov 2022 13:36

RNS Number : 8140H
Accrol Group Holdings PLC
28 November 2022
 

28 November 2022

 

Accrol Group Holdings plc

("Accrol" or the "Group")

 

Launch of second Environmental, Social and Governance Report

 

Accrol, the UK's leading independent tissue converter, is pleased to announce that it has today published its latest Environmental, Social and Governance ("ESG") Report, which is available on the Group's website: https://www.accrol.co.uk/esg/  

 

Gareth Jenkins, Chief Executive Officer of Accrol, said:

 

"Since the launch of our maiden ESG report a year ago, Accrol's ESG agenda has become even more integral to how we do business. Our approach to ESG makes clear the KPIs and measures we've set ourselves, so our stakeholders understand how our ESG framework shapes performance and the standards set.

 

It enables us to stay focused on long-term sustainable commercial success not just short-term return. It's great to share some of these examples with you in this year's report."

 

Key report highlights

 

Environmental performance:

· 15% reduction in tissue waste

· 3% reduction in energy use

· 8% reduction in carbon emissions and still a business in growth

· 15% more rolls per journey achieved removing c.12% trucks off the road

 

Social performance:

· Living Wage accredited employer - the only accredited UK tissue manufacturer

· Zero lost-time accidents

· Engaged workforce with 89% colleagues proud to work for Accrol

· 22% of females in leadership roles (+6% vs 2020)

 

Governance performance:

· All sites A or AA BRCGS accredited providing trusted reassurance to leading retailers

· Compliant Sedex member supporting responsible and sustainable business and supply chain decisions

· Supplier code of conduct launched

 

This announcement has been released as a Reach announcement.

 

For further information, please contact:

 

 

Accrol Group Holdings plc

Dan Wright, Executive Chairman

Via Belvedere Communications

Gareth Jenkins, Chief Executive Officer

Richard Newman, Chief Financial Officer

 

Belvedere Communications Limited

Cat Valentine

Tel: +44 (0) 7715 769 078

Keeley Clarke

Tel: +44 (0) 7967 816 525

accrolpr@belvederepr.com

 

Overview of Accrol

 

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. The Group now operates from six manufacturing sites, including four in Lancashire, which now supplies 21.5% (volume) of the UK tissue market valued at £2.1bn at retail sales value.

 

The Group has produced a short video to showcase its operations and investment in the extensive automation of the business. Click here: Accrol Today.

 

For more information, please visit www.accrol.co.uk

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABXBDBXXDDGDI
Date   Source Headline
22nd May 20187:00 amRNSOpen Offer
22nd May 20187:00 amRNSTR1
15th May 20185:16 pmRNSPosting of Circular
15th May 20183:08 pmRNSProposed Placing to raise £8 million
3rd May 20187:00 amRNSHolding(s) in Company
1st May 20182:06 pmRNSSecond Price Monitoring Extn
1st May 20182:00 pmRNSPrice Monitoring Extension
1st May 20187:00 amRNSRevised Banking Arrangements & Operational Update
4th Apr 20185:06 pmRNSDirector Shareholding
29th Mar 20183:26 pmRNSTR1: Standard form
29th Mar 20187:00 amRNSTR-1: Standard form
27th Mar 20183:43 pmRNSStatement re Share Price Movement
26th Mar 20184:41 pmRNSSecond Price Monitoring Extn
26th Mar 20184:35 pmRNSPrice Monitoring Extension
21st Mar 201812:32 pmRNSHolding(s) in Company
19th Mar 20187:00 amRNSTrading Update
15th Feb 20185:55 pmRNSDirector/PDMR Shareholding
13th Feb 20187:00 amRNSDirector/PDMR Shareholding
8th Feb 20184:31 pmRNSDirector/PDMR Shareholding
5th Feb 20187:00 amRNSBoard Changes
23rd Jan 20181:16 pmRNSPDMR Dealings
22nd Jan 20187:01 amRNSInterim Results for six months ended 31 Oct 2017
22nd Jan 20187:00 amRNSBoard Change
17th Jan 20183:25 pmRNSUpdate on Health and Safety Incident
4th Jan 20187:00 amRNSTR-1: Standard form
3rd Jan 20187:00 amRNSNotice of Half Year Results
13th Dec 201710:57 amRNSHolding(s) in Company
12th Dec 20177:00 amRNSHolding(s) in Company
11th Dec 20178:02 amRNSDirectors' Dealings
11th Dec 20178:01 amRNSPlacing Shares Admitted
8th Dec 201711:09 amRNSResult of General Meeting
30th Nov 20177:00 amRNSReplacement - TR-1
29th Nov 20172:05 pmRNSTR-1: Standard form
21st Nov 20174:40 pmRNSSecond Price Monitoring Extn
21st Nov 20174:35 pmRNSPrice Monitoring Extension
21st Nov 20177:00 amRNSPosting of Circular
20th Nov 20177:30 amRNSRestoration - Accrol Group Holdings Plc
20th Nov 20177:00 amRNSProposed Placing of £18m and Lifting of Suspension
12th Oct 20174:05 pmRNSUpdate on Health and Safety incident
9th Oct 20177:00 amRNSUpdate on Suspension of Trading on AIM
5th Oct 20177:30 amRNSSuspension - Accrol Group Holdings Plc
5th Oct 20177:00 amRNSTrading Update and Temporary Suspension of Trading
22nd Sep 20172:47 pmRNSResult of AGM
19th Sep 20173:16 pmRNSHolding(s) in Company
7th Sep 20177:00 amRNSAppointment of Chief Executive and Trading Update
10th Aug 20177:00 amRNSPosting of Accounts & Notice of AGM (Replacement)
9th Aug 20177:00 amRNSPosting of Accounts & Notice of AGM - Date change
10th Jul 20177:01 amRNSAppointment of Joint Corporate Broker
10th Jul 20177:00 amRNSPreliminary results for year ended 30 April 2017
26th Jun 20179:06 amRNSInvestment in new manufacturing line for Leyland

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.